CDK4 and breast cancer: β-Thujaplicin is a natural monoterpenoid that can induce G0/G1 phase cell-cycle arrest, as well as regulate cell-cycle mediators, cyclin D1, cyclin E, and CDK4, thereby inhibiting the proliferation of ER- basal-like MCF10DCIS.com human BC cells [156].